Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ribosomal protein L39 pseudogene 17 (RPL39P17) is a processed pseudogene located in the human genome. Unlike canonical ribosomal protein genes, pseudogenes such as RPL39P17 do not code for a functional protein. Pseudogenes result from duplication or retrotransposition events and may contain sequence similarities to their functional counterparts but typically lack coding potential or biological activity. There is no evidence that RPL39P17 produces a functional protein or is involved in recognized biological pathways or disease processes. It is not listed as a target for drugs or as a therapeutic biomarker.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ribosomal protein L39 pseudogene 17 (RPL39P17).